Explore Recommendation Statements and accompanying evidence reports about cancer screening and prevention and more from the USPSTF.
This study compares the 2021 US Preventive Services Task Force lung cancer screening criteria with other lung cancer screening criteria and evaluates whether the sensitivity and specificity of these criteria differ by race.
This US Preventive Services (USPSTF) Policy Report describes strategies developed by the USPSTF to mitigate the influence of systemic racism in its recommendations and to promote health equity in preventive services.
This Methods Report from the US Preventive Services Task Force (USPSTF) summarizes definitional and conceptual issues around racism and health inequity and describes how racism and health inequities are currently addressed in preventive health.
This 2021 Recommendation Statement from the US Preventive Services Task Force recommends that primary care clinicians prescribe oral fluoride supplementation starting at age 6 months for children whose water supply is deficient in fluoride (B recommendation) and apply fluoride varnish to the primary teeth of all children starting at the age of primary tooth eruption (B recommendation) and concludes that current evidence is insufficient to assess the benefits and harms of routine primary care dental caries screening in children younger than 5 years (I statement).
This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on screening and interventions to prevent dental caries in children summarizes published evidence on the benefits and harms of screening and interventions provided by primary care clinicians to prevent dental caries in children younger than 5 years.
This JAMA Patient Page describes the US Preventive Services Task Force’s recommendations on screening and interventions to prevent dental caries in young children.
This economic evaluation assessed the cost-effectiveness of the 2021 US Preventive Services Task Force recommendation for lung cancer screening compared with the 2013 recommendation and alternative screening strategies.
This quality improvement study evaluates lung cancer screening eligibility among US Black women under the 2013 and 2021 USPSTF guidelines.
This report describes methods used by the US Preventive Services Task Force (USPSTF) to identify USPSTF recommendations that have sex or gender components and clarify the populations for which the recommendations should apply and also proposes an approach to making recommendations that are respectful of gender diversity.
This cohort study uses deidentified claims data from Blue Cross Blue Shield beneficiaries aged 40 to 89 years to evaluate changes in rates of prostate-specific antigen testing after the 2017 revision of the US Preventive Services Task Force guideline on prostate cancer screening.
This report from the US Preventive Services Task Force (USPSTF) identifies how social risks have been considered in the USPSTF recommendation statements and provides a foundation for ongoing work to ensure that health equity and social risks are incorporated in USPSTF methods and recommendations.
This technical brief to support the US Preventive Services Task Force (USPSTF) describes current research on screening and interventions for social risk factors such as food insecurity, financial strain, and housing instability to inform USPSTF considerations of the implications for its portfolio of recommendations.
This cohort study examines the latest expansion of the lung cancer screening eligibility criteria for adults in the US.
This 2021 Recommendation Statement from the US Preventive Services Task Force recommends the use of low-dose aspirin (81 mg/d) as preventive medication for preeclampsia after 12 weeks of gestation in persons at high risk for preeclampsia (B recommendation).
This systematic review to support the 2021 US Preventive Services Task Force Recommendation Statement on aspirin use to prevent preeclampsia and related morbidity and mortality summarizes published evidence on the benefits and harms of aspirin use in individuals at increased preeclampsia risk based on clinical risk factors or measurements associated with higher disease incidence.
This JAMA Patient Page summarizes the US Preventive Services Task Force’s recent recommendations on using aspirin during pregnancy to prevent preeclampsia and preeclampsia-related complications.
Customize your JAMA Network experience by selecting one or more topics from the list below.